Intec Pharma Ltd. (NASDAQ:NTEC) and Anika Therapeutics Inc. (NASDAQ:ANIK) compete with each other in the Biotechnology sector. We will analyze and compare their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation.
Earnings and Valuation
Demonstrates Intec Pharma Ltd. and Anika Therapeutics Inc. earnings per share, gross revenue and valuation.
Table 2 demonstrates the net margins, return on assets and return on equity of Intec Pharma Ltd. and Anika Therapeutics Inc.
In next table is given Intec Pharma Ltd. and Anika Therapeutics Inc.’s ratings and recommendations.
On the other hand, Anika Therapeutics Inc.’s potential downside is -4.02% and its consensus price target is $38.67.
Institutional Insider Ownership
Institutional investors held 40.23% of Intec Pharma Ltd. shares and 87.1% of Anika Therapeutics Inc. shares. Intec Pharma Ltd.’s share held by insiders are 16.08%. On